The role provides strategic regulatory leadership for the advancement of gene editing therapies at Verve Therapeutics, a subsidiary of Eli Lilly & Company.
Base: $267,000 - $391,600; Bonus/Equity: Eligible for company bonus based on performance; Benefits: Comprehensive program including 401(k), medical, dental, vision, and wellness perks
Must-have
Nice-to-have
Not specified